Observation of Inhalation of CXMCI-01 Essential Oil on Patients With Mild Cognitive Impairment

NCT06902181 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment

Interventions

BEHAVIORAL: Experimental Group - 100% CXMCI-01 Essential Oil
BEHAVIORAL: Control Group - 0.1% CXMCI-01 Essential Oil (placebo)

Sponsor

China Medical University Hospital